TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01786187

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Light Physical Activity
Description: Conventional treatment for cancer as prescribed by the participant's health care providers and will receive a home-based light physical activity program to help manage a specific symptom related to cancer and cancer treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Symptom Experience Report
Description: Conventional treatment for cancer as prescribed by the participant's health care providers and will receive planned, structured, weekly telephone visits to report the experience of symptoms and health-related quality of life information.
Study: NCT01506453

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gabapentin
Description: Participants randomized to the active treatment arm will receive gabapentin 20mg/kg/day PO divided into 3 doses and rounded to the nearest 100 mg for capsules and 10 mg for liquid preparation.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Participants randomized to the placebo treatment arm will receive look-alike capsules or liquid in a respective capsule size or liquid measure equivalent to the active treatment arm, but which contain no active treatment.
Study: NCT00950222

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imipenem/Amikacin
Description: patients will received as empirical therapy for VAP imipenem associated with amikacin.
Study: NCT04538443

Intervention type: OTHER
Intervention: functional capacity
Description: impact of hemodialysis on functional capacity in children with CKD

Intervention type: OTHER
Intervention: muscle strength
Description: impact of hemodialysis on muscle strength in children with CKD

Intervention type: OTHER
Intervention: Quality of life of children
Description: impact of hemodialysis on Quality of life in children with CKD
Study: NCT04538443

Intervention type: OTHER
Intervention: Quality of life of families
Description: impact of hemodialysis on Quality of life of families of children with CKD
Study: NCT04634929

Intervention type: PROCEDURE
Intervention: bariatric surgery
Description: bariatric surgery

Intervention type: DIETARY_SUPPLEMENT
Intervention: conservative diet
Description: conservative diet
Study: NCT01328717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Contour Link Investigational Blood Glucose Monitoring System
Description: Subjects with diabetes and study staff each performed Blood Glucose tests from the subject's capillary blood obtained from fingerstick using the Contour Link investigational meter.
Study: NCT04323631

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Oral

Intervention type: OTHER
Group type: OTHER
Intervention: The control group will not receive hydroxychloroquine
Description: The control group will not receive hydroxychloroquine
Study: NCT01548079

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ursodeoxycholic Acid (UDCA)
Description: 20mg/kg/day UDCA in three weeks
Study: NCT01574391

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Epidrum
Description: Epidrum is used
Study: NCT01944150

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Description: explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse during 30 minutes lasting session

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation and hypnosis
Description: explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse. Following informations are collected by the second nurse: pain representation and its relief thoughts about a quiet place. TENS and hypnosis are associated in a unique 30 minutes session
Study: NCT03407443

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exposure to Make the Connection messages
Description: Participants are exposed to Make the Connection messages (each approximately 3 minutes in length) weekly for over a four-month study period through the study mobile application.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Control Group
Description: Participants are exposed to VA news clips/segments (each approximately 3 minutes in length) weekly for over a four-month study period through the study mobile application.
Study: NCT01978522

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Randomisation of questionnaire receipt.
Description: 1. The self-completion questionnaire will be delivered to the participants via post a week after completing the CAPI.~2. Self-completion questionnaire handed to participants immediately after completing the CAPI.
Study: NCT04049786

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serial blood sampling for PK analysis
Description: Serial blood samples are being collected at times 0, 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12, 15, 18 and 24 hours after drug administration for PK evaluation .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoprolol 100 mg for CYP2D6 phenotyping
Description: Metoprolol is being used as probe drug to evaluate CYP2D6 activity. Single-dose of metoprolol 100 mg are being administrated orally.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoprolol 100 mg for CYP2D6 phenotyping
Description: Metoprolol is being used as probe drug to evaluate CYP2D6 activity. Single-dose of metoprolol 100 mg are being administrated orally.
Study: NCT03059225

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation (rTMS)
Description: undergo contralesional 1Hz repetitive transcranial magnetic stimulation(rTMS) or high frequency ipsilesional rTMS for 10 daily sessions

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation (rTMS)
Description: undergo contralesional 1Hz repetitive transcranial magnetic stimulation(rTMS) or high frequency ipsilesional rTMS for 10 daily sessions

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: 2-week inhibitory non-dominate hemisphere rTMS program
Study: NCT04719325

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Herbert screw
Description: Fracture line exposed through intra-oral approach. bone reduction into proper anatomical occlusion and application of Herbert screw

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lag screw
Description: Fracture line exposed through intra-oral approach. bone reduction into proper anatomical occlusion. Application of either lag screw according to Champy's osteosynthesis lines.
Study: NCT02035592

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Full dose blueberry
Description: Full dose: 26g of freeze dried blueberry powder to be incorporated into the habitual diet.~Dietary restrictions will be observed (i.e. avoidance of blueberry, and restricted intake of anthocyanin rich foods) for 21 days prior to the first assessment visit and throughout the study.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Half dose blueberry
Description: Half dose: 26g of freeze dried powder (containing 13g of freeze dried blueberry powder and 13g of placebo comparator material) to be incorporated into the habitual diet.~Dietary restrictions will be observed (i.e. avoidance of blueberry, and restricted intake of anthocyanin rich foods) for 21 days prior to the first assessment visit and throughout the study.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Control: 26g of placebo comparator material to be incorporated into the habitual diet.~Dietary restrictions will be observed (i.e. avoidance of blueberry, and restricted intake of anthocyanin rich foods) for 21 days prior to the first assessment visit and throughout the study.